Home › Trial NCT04784689
Host Immune Response to Novel RNA COVID-19 Vaccination
- Trial IDNCT04784689
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorThe University of Texas Health Science Center at San Antonio
- Enrollment50
- Start date2021-02-24
- ConditionsCOVID-19 Vaccine · Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.